Litcius/Paper detail

Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial

Ki Hong Choi, Yong Hwan Park, Jong‐Young Lee, Jin‐Ok Jeong, Chan Joon Kim, Kyeong Ho Yun, Han Cheol Lee, Kiyuk Chang, Mahn‐Won Park, Jang‐Whan Bae, Joon‐Hyung Doh, Byung Ryul Cho, Hee-Yeol Kim, Weon Kim, Ung Kim, Seung‐Woon Rha, Young Joon Hong, Hyun‐Jong Lee, Sung Gyun Ahn, Doo‐Il Kim, Jang Hyun Cho, Sung‐Ho Her, Doo Soo Jeon, Seung Hwan Han, Jin Bae Lee, Cheol Whan Lee, Danbee Kang, Joo Myung Lee, Taek Kyu Park, Jeong Hoon Yang, Soo‐Youn Lee, Seung-Hyuk Choi, Hyeon‐Cheol Gwon, Young Bin Song, Joo-Yong Hahn

2025The Lancet77 citationsDOI

Topics & Concepts

MedicineClopidogrelAspirinPercutaneous coronary interventionCardiovascular eventInternal medicineRandomized controlled trialOpen labelConventional PCICardiologyEmergency medicineMyocardial infarctionAntiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and DiagnosticsAcute Myocardial Infarction Research